CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa
Neurophysiological Effects of Cognitive-Behavioral Therapy in Anorexia Nervosa: A Pre-Post EEG, GSR, and Eye-Tracking Study
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial investigates the neurophysiological, physiological, and attentional effects of Cognitive-Behavioral Therapy (CBT) in individuals with restrictive-type anorexia nervosa (AN). The study compares two groups: one receiving a 12-week CBT intervention, and one placed on a waitlist (no active treatment during the study period). All participants undergo pre- and post-intervention assessments using electroencephalography (EEG), galvanic skin response (GSR), and eye-tracking while exposed to visual stimuli related to food, body image, and self-appearance. The primary outcomes include neural changes in attention and emotional processing (P300, LPP, frontal alpha asymmetry), physiological arousal (skin conductance), and visual attention biases (fixation duration and gaze distribution). The aim is to determine whether CBT leads to measurable improvements in neurobiological and attentional mechanisms related to body image disturbance and food-related anxiety in AN, contributing to biomarker-informed psychotherapy approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2025
CompletedFirst Submitted
Initial submission to the registry
June 17, 2025
CompletedFirst Posted
Study publicly available on registry
June 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2025
CompletedJune 25, 2025
June 1, 2025
4 months
June 17, 2025
June 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in EEG P300 amplitude in response to body image stimuli
P300 amplitudes will be extracted from EEG data during visual exposure to body image stimuli. Reduced amplitudes post-CBT are hypothesized to indicate reduced attentional salience and hyperfocus on appearance-related cues. P300 amplitudes will be extracted from EEG data during visual exposure to body image stimuli. Reduced amplitudes post-CBT are hypothesized to indicate reduced attentional salience and hyperfocus on appearance-related cues.
aseline and Week 12
Change in Late Positive Potential (LPP) amplitude to body and food stimuli
LPP amplitudes will be measured during viewing of thin, overweight, and food-related images. A reduction post-CBT suggests decreased sustained emotional reactivity to distressing visual input.
Baseline and Week 12
Change in frontal alpha asymmetry during self-image viewing
Frontal alpha asymmetry (FAA), computed from EEG data, will be used to index emotional regulation. An increase in left-dominant FAA is expected post-CBT, reflecting enhanced emotional control and positive self-perception.
Baseline and Week 12
Change in skin conductance response (SCR) to body and food stimuli
Skin conductance responses will be measured via GSR during visual exposure to self-body, other-body, and food stimuli. Decreased SCR amplitudes post-CBT will indicate reduced physiological arousal and distress.
Baseline and Week 12
Change in fixation duration on weight-related body areas
Eye-tracking will assess gaze fixation duration on areas of interest (waist, thighs, stomach). Post-CBT reductions in fixation on these regions suggest reduced attentional bias toward body dissatisfaction zones.
Baseline and Week 12 Baseline and Week 12
Secondary Outcomes (6)
Change in Eating Disorder Examination Questionnaire (EDE-Q) scores
Baseline and Week 12
Change in Beck Depression Inventory-II (BDI-II) scores
Baseline and Week 12
Change in Beck Anxiety Inventory (BAI) scores
Baseline and Week 12
Change in Yale-Brown Obsessive Compulsive Scale - Body Dysmorphic Disorder Version (YBOCS-BDD) scores
Baseline and Week 12
Change in Cognitive Emotion Regulation Questionnaire (CERQ) scores
Baseline and Week 12
- +1 more secondary outcomes
Study Arms (2)
CBT Intervention Group
EXPERIMENTALParticipants diagnosed with restrictive-type anorexia nervosa will receive 12 weekly individual Cognitive-Behavioral Therapy (CBT) sessions. Each session will last approximately 60 minutes and be delivered by a trained therapist. The CBT protocol targets body image distortion, cognitive restructuring of maladaptive beliefs, exposure to food-related stimuli, emotional regulation strategies, and behavioral experiments to reduce avoidance. Pre- and post-treatment neurophysiological (EEG), physiological (GSR), and attentional (eye-tracking) assessments will be conducted.
Waitlist Control Group
NO INTERVENTIONParticipants diagnosed with restrictive-type anorexia nervosa will be placed on a waitlist and will not receive any structured psychological intervention during the 12-week study period. They will complete the same neurophysiological (EEG), physiological (GSR), and attentional (eye-tracking) assessments at baseline and at the 12-week follow-up.
Interventions
Manualized 12-week CBT protocol focused on reducing body image disturbance, distorted beliefs about food and appearance, and avoidance behaviors in individuals with anorexia nervosa. The intervention incorporates psychoeducation, cognitive restructuring, emotional regulation, food exposure, and body image work.
Eligibility Criteria
You may qualify if:
- Female participants aged 18 to 35
- Meeting DSM-5 diagnostic criteria for restrictive-type anorexia nervosa
- Body Mass Index (BMI) between 15.0 and 18.5
- Medically stable to participate in psychological and neurophysiological assessments
- Willingness to participate in weekly therapy sessions (for the CBT group) and to complete pre- and post-assessments
- Ability to provide informed consent
You may not qualify if:
- Current or past diagnosis of bulimia nervosa, binge-eating disorder, or other eating disorders
- Presence of comorbid severe psychiatric disorders (e.g., psychosis, bipolar disorder, substance use disorder)
- History of neurological illness or traumatic brain injury
- Use of psychotropic medication within the last 6 weeks
- Prior participation in structured Cognitive-Behavioral Therapy for an eating disorder
- Pregnancy
- Visual or neurological impairments that would prevent accurate EEG, GSR, or eye-tracking recordings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul Nisantasi Universitylead
- Uskudar Universitycollaborator
- Beykoz Universitycollaborator
Study Sites (1)
Üsküdar University Neuro Marketing Lab.
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gökben Hızlı Sayar, Professor
Üsküdar University
- STUDY DIRECTOR
Eda Yılmazer, Phd
Beykoz University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 17, 2025
First Posted
June 25, 2025
Study Start
May 15, 2025
Primary Completion
September 15, 2025
Study Completion
October 15, 2025
Last Updated
June 25, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- IPD and supporting materials will be available beginning 6 months after publication of the primary results and will remain available for up to 5 years upon request.
- Access Criteria
- Qualified researchers affiliated with academic institutions may request access to the IPD and supporting materials for ethically approved secondary analyses. Requests must include a brief research proposal and will be reviewed by the study investigators. Data will be shared via secure institutional transfer platforms upon data use agreement. Qualified researchers affiliated with academic institutions may request access to the IPD and supporting materials for ethically approved secondary analyses. Requests must include a brief research proposal and will be reviewed by the study investigators. Data will be shared via secure institutional transfer platforms upon data use agreement.
De-identified individual participant data (IPD) for all primary and secondary outcome measures (EEG, GSR, eye-tracking, and psychometric scores) will be shared upon reasonable request. Data will be shared in compliance with institutional ethics and data protection regulations.